Symposium | Q&A session
The Multiple Myeloma Hub virtual symposium held on March 11, 2024 entitled “Current and future perspectives for bispecific antibodies in multiple myeloma: Le…
The Multiple Myeloma Hub virtual symposium held on March 11, 2024 entitled “Current and future perspectives for bispecific antibodies in multiple myeloma: Le…
View Full-Length Video at: https://youtu.be/MquzOMGDI8kRelated Article Available at: https://mayocl.in/3JaDmRx
OCE experts regularly join colleagues to participate in major conferences.
On this page you can find all the information regarding the registration fees, process and applicable terms to attend the EHA2024 Hybrid Congress. Join us…
Results from the phase III TRIANGLE trial indicate that the addition of ibrutinib to immunochemotherapy and autologous stem cell transplantation (ASCT) significantly improved failure-free survival…
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
For Melanoma and Skin Cancer Awareness Month, Nayoung Lee, MD, discussed evolving paradigms in skin cancer diagnosis and prevention.
Neoadjuvant nivolumab plus chemotherapy is standard therapy for resectable non–small-cell lung cancer. Whether the addition of adjuvant nivolumab may improve…
Learn more about a 56-year-old woman diagnosed with well-differentiated papillary mesothelioma, and how she was diagnosed and properly treated.
Valerae Lewis, M.D., is a leader in the field of orthopedic oncology and chairs MD Anderson’s Orthopaedic Oncology department. Here, she shares what led her…